Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
€50 million investment integrates the latest construction and environmental standards.
October 21, 2020
By: Contract Pharma
Contract Pharma Staff
Vetter, a global contract development and manufacturing organization (CDMO), has moved into its new headquarters in Ravensburg, Germany. The opening of the new building, known as Ravensburg Vetter Kammerbruehl. While the situation regarding the coronavirus continues to shift, Vetter is doing what is necessary to continue being a stable and reliable partner for its customers and suppliers. As a CDMO, the company works together with its clients to continue enabling the supply of oftentimes life-saving drugs to patients worldwide. With the realization of the new corporate headquarters, Vetter is responding to the continuous growth of headcount and changing circumstances. “We are relying on sustainable and future-oriented activities with the focus on our customers and their patients,” said Peter Soelkner, managing director, Vetter. “The new building is designed for around 1,000 employees. In addition to an appropriate level of office space, it includes the new ATRIUM company restaurant, a cafeteria and about 40 conference rooms. Vetter attaches great importance to modernity and, as such, has invested roughly €50 million in a building that integrates the latest construction and environmental standards.” The former headquarters, Ravensburg Vetter Verwaltung, was modified to be used as a training center to house the Vetter Academy. Through this education center the company offers employees qualification programs and individual development opportunities on a continuous basis. In addition, a separate floor in the building is now used as an audit and conference location. The CDMO has set also high goals for its other sites. Most recently, a new combination building for manual visual inspection and secondary packaging started operations at the Ravensburg Vetter Sued / Vetter Secondary Packaging site. Furthermore, a new cleanroom for the manufacturing of prefilled syringes is planned for going operational at the Schuetzenstrasse site in 2021. At this location, Vetter has also secured an adjoining plot of land for a further production building. Meanwhile, the recently purchased clinical manufacturing site in Rankweil, Austria, is designed to be ready for the first drug products in development in the second half of 2021. “Part of our 360-degree approach includes investments in the expansion of our development capacities,” said Soelkner. “We have observed a steady increase in demand from our customers as well as ever-more complex requirements for modern compounds.” The company has responded to these needs at both its Schuetzenstrasse site as well as at the company’s dedicated US clinical manufacturing site. “Our goal is to expand our production capacities sustainably and to align the upstream and downstream areas accordingly,” said managing director Thomas Otto. In the coming years, the company also intends to further expand on its quality control resources. Following the recent implementation of another machine for automated visual inspection, the CDMO is planning to purchase three additional units for its Center for Visual Inspection and Logistics. “We want to provide sufficient resources for the important step of final quality control and, at the same time, create greater flexibility,” said Otto. “These actions will even better enable us to offer our customers either manual or automatic visual inspection depending on individual batch sizes and special characteristics of their products.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !